<DOC>
	<DOCNO>NCT02522988</DOCNO>
	<brief_summary>The purpose randomized-controlled , crossover pilot trial evaluate feasibility , acceptability effect non-deceptive ( open-label ) administration placebo pill treat cancer relate fatigue ( CRF ) . If significant effect find , investigator later determine presence COMT Val18Met genotype variant predict placebo response .</brief_summary>
	<brief_title>The Use Open Label Placebo Treat Cancer Related Fatigue Cancer Survivors</brief_title>
	<detailed_description>The investigator conduct pilot randomized-controlled , crossover trial evaluate feasibility , acceptability effect open-label administration placebo pill CRF associate psychosocial factor ( e.g. , emotional health , social health , quality life , etc . ) cancer survivor ( CSs ) complete cancer treatment yet continue experience CRF . Additionally , exploratory manner , investigator collect DNA saliva specimen analyze potential biomarkers may predict placebo response . To , investigator use 7-week , single site , two-parallel arm , randomize control crossover pilot study determine feasibility , acceptability effect Open Label Placebo Intervention ( OLPI ) CSs complete cancer treatment least 6 month prior enrollment study report fatigue score 4 great 0-10 scale . Investigators enroll 80 eligible CS participant randomize two group 40 ( Group1 Group2 ) . In crossover study , participant Group1 , receive OLP ( placebo pill ) 21-days ( Period 1 ) Group2 ( Observational Controls ) . After 1-week washout period , Group2 receive OLP 21-days ( Period 2 ) Group1 ( Observational Controls ) .</detailed_description>
	<mesh_term>Fatigue</mesh_term>
	<criteria>Clinical diagnosis Stage II IV cancer ; Completed primary treatment 6months 10 year ; Report â‰¥4 ( moderate fatigue ) 010 fatigue severity rating scale ; Agree change medication treatment study ; Willingness make 4 clinical site visit course 49day study . Stage 1 cancer ; Uncontrolled diabetes ; Uncontrolled COPD ; Uncontrolled ischemic heart disease ; Uncontrolled liver/kidney disease ; Uncontrolled autoimmune disease ; Uncontrolled psychiatric cognitive disease .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>cancer-related fatigue</keyword>
</DOC>